Literature DB >> 10408740

Managing alcohol withdrawal in the elderly.

K L Kraemer1, J Conigliaro, R Saitz.   

Abstract

The alcohol withdrawal syndrome is common in elderly individuals who are alcohol dependent and who decrease or stop their alcohol intake. While there have been few clinical studies to directly support or refute the hypothesis that withdrawal symptom severity, delirium and seizures increase with advancing age, several observational studies suggest that adverse functional and cognitive complications during alcohol withdrawal do occur more frequently in elderly patients. Most elderly patients with alcohol withdrawal symptoms should be considered for admission to an inpatient setting for supportive care and management. However, elderly patients with adequate social support and without significant withdrawal symptoms at presentation, comorbid illness or past history of complicated withdrawal may be suitable for outpatient management. Although over 100 drugs have been described for alcohol withdrawal treatment, there have been no studies assessing the efficacy of these drugs specifically in elderly patients. Studies in younger patients support benzodiazepines as the most efficacious therapy for reducing withdrawal symptoms and the incidence of delirium and seizure. While short-acting benzodiazepines, such as oxazepam and lorazepam, may be appropriate for elderly patients given the risk for excessive sedation from long-acting benzodiazepines, they may be less effective in preventing seizures and more prone to produce discontinuation symptoms if not tapered properly. To ensure appropriate benzodiazepine treatment, dose and frequency should be individualised with frequent monitoring, and based on validated alcohol withdrawal severity measures. Selected patients who have a history of severe or complicated withdrawal symptoms may benefit from a fixed schedule of benzodiazepine provided that medication is held for sedation. beta-Blockers, clonidine, carbamazepine and haloperidol may be used as adjunctive agents to treat symptoms not controlled by benzodiazepines. Lastly, the age of the patient should not deter clinicians from helping the patient achieve successful alcohol treatment and rehabilitation.

Entities:  

Mesh:

Year:  1999        PMID: 10408740     DOI: 10.2165/00002512-199914060-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  170 in total

Review 1.  Geriatric substance use disorders.

Authors:  M C Reid; P A Anderson
Journal:  Med Clin North Am       Date:  1997-07       Impact factor: 5.456

Review 2.  Alcoholism and dementia.

Authors:  D M Smith; R M Atkinson
Journal:  Int J Addict       Date:  1995 Nov-Dec

3.  Controlled trial comparing amobarbital and clomethiazole in alcohol withdrawal symptoms.

Authors:  M J Harfst; J G Greene; F G Lassae
Journal:  Q J Stud Alcohol       Date:  1967-12

4.  Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.

Authors:  M L Palestine; E Alatorre
Journal:  Curr Ther Res Clin Exp       Date:  1976-09

5.  Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial.

Authors:  T M Worner
Journal:  Am J Drug Alcohol Abuse       Date:  1994       Impact factor: 3.829

6.  The kindling hypothesis: further evidence from a U.S. national study of alcoholic men.

Authors:  B M Booth; F C Blow
Journal:  Alcohol Alcohol       Date:  1993-09       Impact factor: 2.826

Review 7.  Alcoholism in older persons: a review of the literature.

Authors:  J G Liberto; D W Oslin; P E Ruskin
Journal:  Hosp Community Psychiatry       Date:  1992-10

8.  Social and clinical features as predictors of outcome in outpatient alcohol withdrawal.

Authors:  P G O'Connor; L D Gottlieb; M L Kraus; S R Segal; R I Horwitz
Journal:  J Gen Intern Med       Date:  1991 Jul-Aug       Impact factor: 5.128

9.  Alcohol withdrawal in the elderly.

Authors:  B I Liskow; C Rinck; J Campbell; C DeSouza
Journal:  J Stud Alcohol       Date:  1989-09

10.  Renal disease, age, and oxazepam kinetics.

Authors:  T G Murray; S T Chiang; H H Koepke; B R Walker
Journal:  Clin Pharmacol Ther       Date:  1981-12       Impact factor: 6.875

View more
  5 in total

Review 1.  Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.

Authors:  Derek J Roberts; Babar Haroon; Richard I Hall
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

2.  Can clinical practice indicator relating to long-acting benzodiazepine use in the elderly be easily generated in a hospital setting?

Authors:  Badria Kadri; Antonio Teixeira; Christelle Duteil; Annabelle Tan; Hélène Barreteau; Christophe Segouin; Pénélope Troude
Journal:  Eur J Clin Pharmacol       Date:  2017-11-16       Impact factor: 2.953

Review 3.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 4.  A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review).

Authors:  Simona Trifu; Andrian Țîbîrnă; Radu-Virgil Costea; Alexandra Popescu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

5.  Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study.

Authors:  Martin Schulze Westhoff; Adrian Groh; Sebastian Schröder; Phileas Johannes Proskynitopoulos; Kirsten Jahn; Martin Klietz; Benjamin Krichevsky; Dirk O Stichtenoth; Felix Wedegärtner; Stefan Bleich; Helge Frieling; Johannes Heck
Journal:  J Neural Transm (Vienna)       Date:  2022-09-02       Impact factor: 3.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.